Morbidity

Percent prevalence of chronic conditions among users of chronic drugs program, 2016*

Chronic conditions	Prevalence
Cardiovascular diseases, atherosclerosis, coagulation problems and hypertension	47%
Diabetes	15%
Ulcers	10%
High cholesterol level	10%
Other diseases (Rheumatism, uric acid, glaucoma, osteoporosis...)	8%
Diseases of the nervous system	3%
Epilepsy	3%
Thyroid Problems	2%
Asthma	2%

*For previous years check the Statistical Bulletins' page

Newly reported HIV cases, 2020

Newly reported HIV cases,2021

Newly reported HIV cases, 2022

New reported HIV cases,2023

New reported HIV cases,2024

https://www.moph.gov.lb/userfiles/files/Prevention/TB%20Program/NTP-NAP%20Annual%20Report-2024.pdf

Number of Measles cases

	2012	2013	2014	2015	2016	2017	2018	2019	2020	2021	2022	2023
Measles	9	1,760	235	39	44	126	952	1070	-	28	95	351

Source :MoPH 01/09/2024

Number of Tuberculosis cases*

Tuberculosis cases	2012	2013	2014	2015	2016	2017	2018	2019	2020	2021	2022	2023	2024
Total number of cases	630	689	682	666	657	632	668	760	656	466	510	510	540
Number of Lebanese cases	330	341	337	312	305	271	254	288	277	233	263	249	225
Number of Non-Lebanese cases	300	348	345	354	352	361	414	472	379	233	247	261	315

*MOPH National Tuberculosis Program 01/05/2025

The trend in Tuberculosis cases by Nationality between 2019 and 2024

...

189

All

ATC	Name	B/G	Ingredients	Dosage	Form	Price
B05XA03	SOLUFLEX SODIUM CHLORIDE 0.9% INJECTION, USP	G	Sodium chloride - 0.9%	0.9%	Injectable solution	218,344 L.L
B05XA03	SOLUFLEX SODIUM CHLORIDE 0.9% INJECTION, USP	G	Sodium chloride - 0.9%	0.9%	Injectable solution	203,405 L.L
B05XA03	SOLUFLEX SODIUM CHLORIDE 0.9% INJECTION, USP	G	Sodium chloride - 0.9%	0.9%	Injectable solution	179,272 L.L
B05XA03	SODIUM CHLORIDE INJECTION/ DEMO	G	Sodium chloride - 0.9% w/v	0.9% w/v	Injectable solution	1,182,581 L.L
B05XA03	SODIUM CHLORIDE INJECTION/ DEMO	G	Sodium chloride - 0.9% w/v	0.9% w/v	Injectable solution	1,419,098 L.L
B05XA03	SODIUM CHLORIDE INJECTION/ DEMO	G	Sodium chloride - 0.9% w/v	0.9% w/v	Injectable solution	567,102 L.L
H01AB01	THYROGEN	BioHuman	Thyrotropin alfa - 0.9mg	0.9mg	Injectable lyophilised powder for solution+diluent	65,558,997 L.L
L01FB01	BESPONSA FOR INJECTION	BioTech	Inotuzumab Ozogamicin - 0.9mg	0.9mg	Injectable powder for suspension	921,176,511 L.L
L01FB01	BESPONSA FOR INJECTION	BioTech	Inotuzumab Ozogamicin - 0.9mg	0.9mg	Injectable powder for suspension	L.L
H01CB05	SIGNIFOR	B	Pasireotide (diaspartate) - 0.9mg/ml	0.9mg/ml	Injectable solution	191,126,390 L.L
V03AB14	PROSULF 1%	B	Protamine sulfate - 50mg/5ml	1%	Injectable solution	8,216,459 L.L
N01AX10	PROPOFOL-LIPURO	B	Propofol - 10mg/ml	1%	Injectable emulsion	1,411,035 L.L
N01AX10	DORMIFOR	G	Propofol - 1%	1%	Injectable emulsion	1,081,473 L.L
N01AX10	PROPOFOL 1% MCT/LCT FRESENIUS	G	Propofol - 1%	1%	Injectable emulsion	847,965 L.L
D08AX02	EOSIN ALCOHOLIC	G	Eosin - 1%	1%	Solution	108,787 L.L
D08AX02	EOSIN AQUEUSE	G	Eosin - 1%	1%	Solution	84,470 L.L
N01BB02	LIDOCAINE ARWAN	G	Lidocaine (HCl) - 1%	1%	Injectable solution	1,995,158 L.L
N01BB02	LIDOCAINE ARWAN	G	Lidocaine (HCl) - 1%	1%	Injectable solution	1,995,158 L.L
N01BB02	? 1% LIDOCAINE HCL USP	G	Lidocaine HCl - 1%	1%	Injectable solution	76,791 L.L
N01BB02	CHLORHYDRATE DE LIDOCAINE RENAUDIN	G	Lidocaine (HCl) - 10mg/ml	1%	Injectable solution	591,291 L.L
N01BB02	LIDOCAINE- ORBUCELL	G	Lidocaine HCl - 1%	1%	Injectable solution	1,787,950 L.L
R06AB02	HISTAMED	G	Dexchlorpheniramine maleate - 1%	1%	Gel	477,384 L.L
P03AB02	GAMMA BENZENE HEXACHLORIDE	G	Lindane - 1%	1%	Shampoo	195,817 L.L
P03AB02	GAMMAPHARM	G	Lindane - 1%	1%	Shampoo	195,817 L.L
P03AB02	GAMMA BENZENE HEXACHLORIDE	G	Lindane - 1%	1%	Lotion	167,660 L.L
P03AC04	PERMACARE	G	Permethrin - 1%	1%	Lotion	590,011 L.L
C05BB02	AETHOXYSKLEROL	B	Polidocanol (Lauromacrogol 400) - 1%	1%	Injectable solution	1,732,213 L.L
D10AF01	CLINIDERM	G	Clindamycin (phosphate) - 1%	1%	Gel	712,876 L.L
D10AF05	NADIXA	G	Nadifloxacin - 1%	1%	Cream	850,652 L.L
D10AF05	NAXIDERM	G	Nadifloxacin - 1%	1%	Gel	826,783 L.L

...

189